Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial

Stock Trading Ideas

Trading Ideas Recent News

Palantir and Nebius Team Up — Bad News for Michael Burry's Short Bets on Both Stocks
Palantir and Nebius Team Up — Bad News for Michael Burry's Short Bets on Both Stocks
Palantir names Nebius its preferred sovereign AI partner, boosting Nebius shares as both companies challenge Michael Burry’s bearish bets.
Nancy Pelosi Bought the Dip on Bloom Energy Stock: Gains are 7x Congressional Salary in Two Months
Nancy Pelosi Bought the Dip on Bloom Energy Stock: Gains are 7x Congressional Salary in Two Months
One of Nancy Pelosi's newest stock pick is already up millions of dollars.
Nebius Shares Rise Nearly 7% After Key Trading Signal
Nebius Shares Rise Nearly 7% After Key Trading Signal
A key trading signal flashed for Nebius shares at a price of $238.59, after which NBIS rose nearly 7% to an intraday high.
Why Oracle Stock is the Trade to Watch After OpenAI's AGI Claim
Why Oracle Stock is the Trade to Watch After OpenAI's AGI Claim
Oracle's $300 billion OpenAI deal makes it an AGI infrastructure proxy. Thursday's earnings will test cloud growth and backlog conversion.
Novartis Myotonic Dystrophy Trial Flop Sends Dyne Therapeutics Shares Tumbling
Novartis Myotonic Dystrophy Trial Flop Sends Dyne Therapeutics Shares Tumbling
Dyne Therapeutics stock sinks on Novartis' failed Phase 3 myotonic dystrophy study, even as Dyne prepares new trial data presentations.
Boston Scientific Says It Won't Meet 2026 Guidance After Cyberattack
Boston Scientific Says It Won't Meet 2026 Guidance After Cyberattack
Boston Scientific expects a 2026 earnings miss after a cyberattack disrupted global operations. Manufacturing and shipping are recovering.
Why Guidewire Stock Dropped After Reporting An Upbeat Quarter
Why Guidewire Stock Dropped After Reporting An Upbeat Quarter
The Guidewire stock drop hit 20% after a Q4 earnings beat. See why soft FY27 guidance and a stretched valuation triggered the sell-off.
Netflix Faces South Africa Price Probe, Putting Stock Under Pressure
Netflix Faces South Africa Price Probe, Putting Stock Under Pressure
Netflix stock dips over 2% following market softness and news that South African regulators are investigating consumer costs for digital streaming services.
Crude Oil Gains 1.5%; ABM Posts Upbeat Q3 Earnings
Crude Oil Gains 1.5%; ABM Posts Upbeat Q3 Earnings
U.S. stocks fell Tuesday as health care lagged, while energy gained. ABM beat estimates; oil rose, and several biotech shares surged or plunged.
Can Visa's Agentic Ready Program Answer The Citrini Bear Case?
Can Visa's Agentic Ready Program Answer The Citrini Bear Case?
Visa Inc. (NYSE:V) expects millions of consumers to use AI agents to complete purchases by the 2026 holiday season. The question for investors is what happens when those agents start deciding not only what to buy, but
Inhibrx Biosciences Plans Head and Neck Cancer Trial Expansion Following High Response Rates
Inhibrx Biosciences Plans Head and Neck Cancer Trial Expansion Following High Response Rates
Inhibrx Biosciences reports Phase 2 HexAgon trial data showing improved response rates for INBRX-106 in head and neck cancer.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved